Advanced Therapeutic Approaches In Type 2 Diabetes is exploring the mystery of how gastric surgery puts Type 2 into remission (note that insulin requirement can disappear in a week after surgery before any weight is actually lost) @ATTDconf #ATTD2021 #dedoc° The suggestion by Dr. Pories is broken gut signalling breaks the glucose processing leading to poor energy production, excess glucose and insulin. #ATTD2021 #dedoc°

Advances in Closed Loop conclusions:
- A more aggressive target improves Time in Range (79% achievable) but does not increase Time Below Range
- Improvements, especially in younger adults when compared to open systems
- Closed Loop is safe.
@ATTDconf #ATTD2021 #dedoc° Moreover, it is as safe for children as adults. #ATTD2021 #dedoc°

The next presentation I'm in is "Artificial intelligence (AI): Tangible Applications to Improve Diabetes Care". AI has come far in the last few years and the poster I mentioned yesterday shows how it can tailor closed loop systems. What else I wonder? @ATTDconf #ATTD2021 #dedoc° Stephane Bidet is saying with as little as 10 days of data, the AI can be trained effectively to smartly manage the user's BGLs. I believe it. Microsoft's Azure AI can effectively read forms with just 5 examples and images with 15 examples. #ATTD2021 #dedoc°

With Dexcom being at the forefront of pumps and CGMs I'm hoping for something special in this one. @ATTDconf #ATTD2021 #dedoc° Control IQ gave users 2.6 hours additional Time in Range over "Sensor Augmented Pumps" (open loop pump therapy) #ATTD2021 #dedoc°

Next is a presentation on Smart Pens for diabetes management @ATTDconf #ATTD2021 #dedoc° The research specifically refers to the Novo Nordisk NovoPen 6 but I'll try to keep it general. #ATTD2021 #dedoc°

Next is Medtronic talking about the outcomes for the first 4,000 users of the MiniMed 780G and the future for this commercial looping system. It will be interesting to see how it stacks up to the homegrown systems. @ATTDconf #ATTD2021 #dedoc° Dr Chantal Mathieu makes the point that the patient living with diabetes gets a few more hours with the disease than their health care team ;) #ATTD2021 #dedoc°

First session at #ATTD2021. As a honeymooning T1D LADA who takes a GLP-1RA to help preserve my beta cells, I'm interested to see what's new with these "Great Little Peptides" #dedoc° @ATTDconf If you are unfamiliar with GLP-1RAs, get the cliff notes here: practicaldiabetic.com/2020/10/10/the… #dedoc° #ATTD2021